📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

TNO155 is a selective SHP2 inhibitor to target PTPN11-dependent oral squamous cell carcinoma (2024)

First Author: Chai A

Attributed to: Mechanism-guided drug repurposing to accelerate the development of novel therapies for oral squamous cell carcinoma (OSCC) funded by Newton Fund

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.heliyon.2024.e39677

Publication URI: http://dx.doi.org/10.1016/j.heliyon.2024.e39677

Type: Journal Article/Review

Parent Publication: Heliyon

Issue: 21